Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Feb-24 9:14 PM View:  | Adcock Richard CEO & President Director | Immunitybio, Inc. (IBRX) | 05-Feb-24 | Payment of Exercise | 43,165 | $4.04 | $174,387.00 | (15%) 286.3K to 243.14K | |
| 06-Feb-24 9:14 PM View: | Adcock Richard CEO & President Director | Immunitybio, Inc. (IBRX) | 05-Feb-24 | Option Exercise | 83,334 | -- | -- | 41% 202.97K to 286.3K | |
| 02-Feb-24 7:38 PM View: | Simon Barry J. Director | Immunitybio, Inc. (IBRX) | 31-Jan-24 | Option Exercise | 57,200 | -- | -- | 2% 3.09M to 3.15M | |
| 02-Feb-24 7:32 PM View: | Gallagher Regan J Chief Accounting Officer | Immunitybio, Inc. (IBRX) | 31-Jan-24 | Option Exercise | 32,872 | -- | -- | 44% 74.93K to 107.8K | |
| 02-Feb-24 7:32 PM View: | Gallagher Regan J Chief Accounting Officer | Immunitybio, Inc. (IBRX) | 31-Jan-24 | Payment of Exercise | 13,470 | $3.36 | $45,259.20 | (12%) 107.8K to 94.33K | |
| 02-Feb-24 7:33 PM View: | Sachs David C. Chief Financial Officer | Immunitybio, Inc. (IBRX) | 31-Jan-24 | Option Exercise | 70,745 | -- | -- | 50% 141.93K to 212.67K | |
| 02-Feb-24 7:38 PM View: | Simon Barry J. Director | Immunitybio, Inc. (IBRX) | 31-Jan-24 | Payment of Exercise | 22,094 | $3.36 | $74,235.80 | (< 1%) 3.15M to 3.12M | |
| 02-Feb-24 7:33 PM View: | Sachs David C. Chief Financial Officer | Immunitybio, Inc. (IBRX) | 31-Jan-24 | Payment of Exercise | 26,835 | $3.36 | $90,165.60 | (13%) 212.67K to 185.84K | |
| 03-Jan-24 9:41 PM View: | Sachs David C. Chief Financial Officer | Immunitybio, Inc. (IBRX) | 31-Dec-23 | Option Exercise | 30,397 | -- | -- | 25% 122.04K to 152.44K | |
| 03-Jan-24 9:40 PM View: | Adcock Richard CEO & President Director | Immunitybio, Inc. (IBRX) | 31-Dec-23 | Option Exercise | 34,483 | -- | -- | 19% 185.58K to 220.06K | |
| 03-Jan-24 9:41 PM View: | Sachs David C. Chief Financial Officer | Immunitybio, Inc. (IBRX) | 31-Dec-23 | Payment of Exercise | 10,511 | $5.02 | $52,765.20 | (7%) 152.44K to 141.93K | |
| 03-Jan-24 9:40 PM View: | Adcock Richard CEO & President Director | Immunitybio, Inc. (IBRX) | 31-Dec-23 | Payment of Exercise | 17,096 | $5.02 | $85,821.90 | (8%) 220.06K to 202.97K | |
| 19-Dec-23 4:41 PM View: | Gallagher Regan J Chief Accounting Officer | Immunitybio, Inc. (IBRX) | 15-Dec-23 | Option Exercise | 21,030 | -- | -- | 39% 53.9K to 74.93K | |
| 13-Sep-23 9:07 PM View: | Soon Shiong Patrick See remarks Director 10% Owner | Immunitybio, Inc. (IBRX) | 11-Sep-23 | Acquisition (other) | 209,292,000 | $1.29 | $269,987,008.00 | 65% 323.24M to 532.54M | |
| 06-Sep-23 7:40 PM View: | Gallagher Regan J Chief Accounting Officer | Immunitybio, Inc. (IBRX) | 01-Sep-23 | Option Exercise | 32,872 | -- | -- | 156% 21.03K to 53.9K | |
| 06-Sep-23 7:41 PM View: | Sachs David C. Chief Financial Officer | Immunitybio, Inc. (IBRX) | 01-Sep-23 | Option Exercise | 70,744 | -- | -- | 138% 51.3K to 122.04K | |
| 06-Sep-23 7:39 PM View: | Simon Barry J. Director | Immunitybio, Inc. (IBRX) | 01-Sep-23 | Option Exercise | 57,199 | -- | -- | 2% 3.03M to 3.09M | |
| 05-Jun-23 9:52 PM View: | Blaszyk Michael D Director | Immunitybio, Inc. (IBRX) | 05-Jun-23 | Private Purchase | 71,915 | $2.75 | $198,023.00 | 37% 193.67K to 265.58K | |
| 05-Jun-23 7:55 PM View: | Brennan John Owen Director | Immunitybio, Inc. (IBRX) | 02-Jun-23 | Private Purchase | 25,000 | $2.83 | $70,700.00 | 100% 0 to 25.0K | |
| 05-Jun-23 7:54 PM View: | Clark Wesley Director | Immunitybio, Inc. (IBRX) | 01-Jun-23 | Private Purchase | 7,000 | $2.91 | $20,370.00 | 700% 1.0K to 8.0K | |
| 07-Feb-23 6:23 PM View: | Adcock Richard CEO & President Director | Immunitybio, Inc. (IBRX) | 05-Feb-23 | Option Exercise | 83,333 | -- | -- | 58% 144.44K to 227.77K | |
| 07-Feb-23 6:23 PM View: | Adcock Richard CEO & President Director | Immunitybio, Inc. (IBRX) | 05-Feb-23 | Payment of Exercise | 42,192 | $4.33 | $182,691.00 | (19%) 227.77K to 185.58K | |
| 04-Jan-23 9:48 PM View: | Adcock Richard CEO & President Director | Immunitybio, Inc. (IBRX) | 31-Dec-22 | Option Exercise | 8,620 | -- | -- | 6% 140.09K to 148.71K | |
| 04-Jan-23 9:48 PM View: | Adcock Richard CEO & President Director | Immunitybio, Inc. (IBRX) | 31-Dec-22 | Payment of Exercise | 4,273 | $5.07 | $21,664.10 | (3%) 148.71K to 144.44K | |
| 04-Jan-23 9:49 PM View: | Sachs David C. Chief Financial Officer | Immunitybio, Inc. (IBRX) | 31-Dec-22 | Option Exercise | 7,598 | -- | -- | 17% 43.7K to 51.3K | |
| 14-Dec-22 4:23 PM View: | Soon Shiong Patrick See remarks Director 10% Owner | Immunitybio, Inc. (IBRX) | 12-Dec-22 | Conversion | 9,986,920 | $5.67 | $56,625,800.00 | 3% 313.26M to 323.24M | 8% |
| 08-Feb-22 8:53 PM View: | Adcock Richard CEO & President Director | Immunitybio, Inc. (IBRX) | 05-Feb-22 | Payment of Exercise | 29,415 | $5.39 | $158,547.00 | (17%) 171.44K to 142.02K | |
| 08-Feb-22 8:53 PM View: | Adcock Richard CEO & President Director | Immunitybio, Inc. (IBRX) | 05-Feb-22 | Option Exercise | 83,333 | -- | -- | 95% 88.11K to 171.44K | |
| 13-Dec-21 4:15 PM View: | Sachs David C. Chief Financial Officer | Immunitybio, Inc. (IBRX) | 09-Dec-21 | Option Exercise | 17,242 | -- | -- | 65% 26.46K to 43.7K | |
| 08-Oct-21 8:31 PM View: | Adcock Richard CEO & President Director | Immunitybio, Inc. (IBRX) | 08-Oct-21 | Market Purchase | 1,930 | $8.81 | $16,995.00 | 2% 86.18K to 88.11K | |
| 13-Sep-21 8:32 PM View: | Adcock Richard Chief Executive Officer Director | Immunitybio, Inc. (IBRX) | 09-Sep-21 | Payment of Exercise | 4,273 | $9.95 | $42,516.30 | (5%) 90.45K to 86.18K | |
| 13-Sep-21 8:34 PM View: | Sachs David C. Chief Financial Officer | Immunitybio, Inc. (IBRX) | 09-Sep-21 | Option Exercise | 7,598 | -- | -- | 40% 18.86K to 26.46K | |
| 13-Sep-21 8:32 PM View: | Adcock Richard Chief Executive Officer Director | Immunitybio, Inc. (IBRX) | 09-Sep-21 | Option Exercise | 8,620 | -- | -- | 11% 81.83K to 90.45K | |
| 24-Aug-21 6:07 PM View: | Cohen Cheryl Director | Immunitybio, Inc. (IBRX) | 23-Aug-21 | Market Sale (Planned) | 14,801 | $10.12 | $149,795.00 | (7%) 215.42K to 200.62K | (7%) |
| 24-Aug-21 6:07 PM View: | Cohen Cheryl Director | Immunitybio, Inc. (IBRX) | 20-Aug-21 | Market Sale (Planned) | 9,976 | $10.00 | $99,807.90 | (4%) 225.39K to 215.42K | (9%) |
| 19-Aug-21 8:42 PM View: | Cohen Cheryl Director | Immunitybio, Inc. (IBRX) | 18-Aug-21 | Market Sale (Planned) | 2,133 | $10.03 | $21,389.10 | (< 1%) 227.53K to 225.39K | 7% |
| 19-Aug-21 8:42 PM View: | Cohen Cheryl Director | Immunitybio, Inc. (IBRX) | 17-Aug-21 | Market Sale (Planned) | 43,398 | $10.12 | $439,361.00 | (16%) 270.93K to 227.53K | 8% |
| 28-Jan-22 10:00 PM View: | Simon Barry J. Director | Immunitybio, Inc. (IBRX) | 04-Jun-21 | Gift | 71,051 | -- | -- | (2%) 3.1M to 3.03M | |
| 25-May-21 8:00 PM View: | Simon Barry J. Director | Immunitybio, Inc. (IBRX) | 25-May-21 | Market Sale | 88,787 | $16.18 | $1,436,820.00 | (3%) 3.19M to 3.1M | 3% |
| 25-May-21 8:00 PM View: | Simon Barry J. Director | Immunitybio, Inc. (IBRX) | 24-May-21 | Market Sale | 21,223 | $16.02 | $340,071.00 | (< 1%) 3.21M to 3.19M | 2% |
| 25-May-21 8:00 PM View: | Simon Barry J. Director | Immunitybio, Inc. (IBRX) | 21-May-21 | Market Sale | 14,990 | $16.09 | $241,164.00 | (< 1%) 3.23M to 3.21M | 2% |
| 07-May-21 4:09 PM View: | Simon Barry J. Director | Immunitybio, Inc. (IBRX) | 05-May-21 | Option Exercise | 56,967 | $1.75 | $99,942.90 | 2% 3.17M to 3.23M | |
| 11-Mar-21 9:30 PM View: | Soon Shiong Patrick Executive Chairman Director 10% Owner | Immunitybio, Inc. (IBRX) | 09-Mar-21 | Acquisition (other) | 237,490,000 | -- | -- | 313% 75.77M to 313.26M | |
| 11-Mar-21 9:30 PM View: | Soon Shiong Patrick Executive Chairman Director 10% Owner | Immunitybio, Inc. (IBRX) | 09-Mar-21 | Acquisition (other) | 5,723,180 | -- | -- | 8% 70.04M to 75.77M | |
| 28-Jan-22 10:00 PM View: | Thomas John C | Immunitybio, Inc. (IBRX) | 23-Feb-21 | Gift | 5,000 | -- | -- | (2%) 221.36K to 216.36K | |
| 09-Feb-21 9:47 PM View: | Adcock Richard Chief Executive Officer | Immunitybio, Inc. (IBRX) | 05-Feb-21 | Option Exercise | 150,000 | -- | -- | 100% 0 to 150.0K | |
| 08-Feb-21 4:54 PM View: | Simon Barry J. See remarks Director | Immunitybio, Inc. (IBRX) | 05-Feb-21 | Market Option Sale (Planned) | 22,100 | $23.09 | $510,267.00 | (< 1%) 3.19M to 3.17M | |
| 09-Feb-21 9:47 PM View: | Adcock Richard Chief Executive Officer | Immunitybio, Inc. (IBRX) | 05-Feb-21 | Payment of Exercise | 68,171 | $23.72 | $1,617,020.00 | (45%) 150.0K to 81.83K | |
| 08-Feb-21 4:54 PM View: | Simon Barry J. See remarks Director | Immunitybio, Inc. (IBRX) | 05-Feb-21 | Option Exercise | 22,100 | $2.00 | $44,164.60 | < 1% 3.17M to 3.19M | |
| 04-Feb-21 6:39 PM View: | Simon Barry J. See remarks Director | Immunitybio, Inc. (IBRX) | 02-Feb-21 | Market Option Sale (Planned) | 82,070 | $20.65 | $1,694,800.00 | (3%) 3.25M to 3.17M | (15%) |
